NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-145-2011-0-ID-06 Plasmodial Surface Anion Channel Inhibitors For The Treatment Of Prevention Of Malaria ID National Stage W00201304646 Issued
NIAID E-145-2011-0-AU-03 Plasmodial Surface Anion Channel Inhibitors For The Treatment Or Prevention Of Malaria AU National Stage 2012242926 Issued
NIA E-049-2001-0-AU-20 GLP-1 Exendin-4 Peptide Analogs and Uses Thereof AU DIV 2012202081 Expired
NCI E-068-2011-0-PCT-02 Human Monoclonal Antibodies That Bind Insulin-Like Growth Factor (IGF) I and II PCT PCT PCT/US2012/033128 Expired
NIAID E-145-2011-0-PCT-02 Plasmodial Surface Anion Channel Inhibitors For The Treatment Of Prevention Of Malaria PCT PCT PCT/US2012/033072 Expired
NCI E-040-2012-0-US-01 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US 61/622,600 Abandoned
NIMH E-044-1997-1-US-13 IMMUNOTOXINS FUSION PROTEINS AND MEANS FOR EXPRESSION THEREOF US DIV 13/443,779 8987426 Expired PDF
NICHD E-157-2011-0-EP-03 Small Molecule Therapeutic Compounds Targeting Thioesterase Deficiency Disorders and Methods of Using the Same EP National Stage 12716889.6 Issued
NICHD E-157-2011-0-PCT-02 Small Molecule Therapeutic Compounds Targeting Thioesterase Deficiency Disorders and Methods of Using the Same PCT PCT PCT/US2012/32772 Expired
NIAID E-150-2011-0-PCT-02 Ubiquitin Fusions For Improving The Efficacy Of Cytosolic Acting Targeted Toxins PCT PCT PCT/US2012/032762 Abandoned
NCI E-086-2012-0-US-01 Methods For Generation Of Pluripotent And Multipotent Cells US 61/621,994 Abandoned
NCI E-131-2011-0-US-02 Nitroxide Modified Non-Steroidal Anti-Inflammatory Compounds And Uses Thereof In The Treatment And Prevention Of Diseases or Disorders US ORD 13/440,092 9012647 Issued PDF
NINDS E-129-2011-2-PCT-01 BO-Based Modulation Of B1 Excitation In MRI PCT PCT COMB PCT/US2012/032387 Expired
NICHD E-084-2012-0-US-01 Polarmetric Accessory For Colposcope US 61/620,295 Abandoned
NCI E-129-2001-0-US-14 Mutuated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. US CON 13/438,725 8809502 Expired PDF
NCI E-232-2009-0-US-06 Human Domain Antibodies Against Components Of The Human Insulin-like Growth Factor (IGF) System US National Stage 13/499,758 9056907 Abandoned PDF
NIDA E-044-2012-0-US-01 Glial Cell Line-Derived Neurotrophic Factor (GDNF) Compositions And Use Thereof US 61/619,296 Abandoned
NCI E-205-2009-0-US-07 Anti-Vascular Endothelial Growth Factor Receptor-2 Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer US National Stage 13/499,349 8465743 Abandoned PDF
NINDS E-113-2011-0-EP-05 WIRELESSLY POWERED MRI SIGNAL AMPLIFICATION SYSTEM AND METHOD EP National Stage 12718473.7 Issued
NINDS E-113-2011-0-GB-10 WIRELESSLY POWERED MRI SIGNAL AMPLIFICATION SYSTEM AND METHOD GB EP 12718473.7 Issued
NINDS E-113-2011-0-DE-08 WIRELESSLY POWERED MRI SIGNAL AMPLIFICATION SYSTEM AND METHOD DE EP 12718473.7 Issued
NINDS E-113-2011-0-NL-11 WIRELESSLY POWERED MRI SIGNAL AMPLIFICATION SYSTEM AND METHOD NL EP 12718473.7 Issued
NINDS E-113-2011-0-FR-09 WIRELESSLY POWERED MRI SIGNAL AMPLIFICATION SYSTEM AND METHOD FR EP 12718473.7 Issued
NINDS E-113-2011-0-AU-03 WIRELESSLY POWERED MRI SIGNAL AMPLIFICATION SYSTEM AND METHOD AU National Stage 2012236492 Issued
NCATS E-326-2008-0-US-08 Activators Of Human Pyruvate Kinase US ORD 13/433,656 8937067 Issued PDF
NINDS E-113-2011-0-PCT-02 WIRELESSLY POWERED MRI SIGNAL AMPLIFICATION SYSTEM AND METHOD PCT PCT PCT/US2012/031083 Expired
NCI E-217-2011-1-US-01 A NOVEL INTERFERON-ANALOG (IFNAN) PROTEIN, RELATED NUCLEIC ACID MOLECULES, AND USES THEREOF US 61/616,664 Abandoned
NCATS E-144-2012-1-US-01 Salicylic Acid Derivatives And Additional Compounds Useful As Glucocerebrosidase Activators US 61/616,773 Abandoned
CC E-541-2013-0-US-01 QUANTITATIVE PERFUSION ANALYSIS FOR EMBOLOTHERAPY US 61/616,926 Abandoned
NCATS E-144-2012-0-US-01 Salicylic Acid Derivatives Useful As Glucocerebrosidase Activators US 61/616,758 Abandoned
CC E-214-2005-0-CA-04 SYSTEM, METHODS, AND INSTRUMENTATION FOR IMAGE GUIDED PROSTATE TREATMENT CA National Stage 2647432 Issued
NCI E-135-2012-0-US-01 DNA METHYLATION ANALYSIS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF ADRENAL NEOPLASMS US 61/615,869 Abandoned
NCI E-264-2011-0-US-01 Novel Delivery Of Packaged RNA In Mammalian Cells US 61/615,687 Abandoned
NIAID E-242-2011-0-EP-04 Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Crystal Structures and Deep Sequencing EP National Stage 12782672.5 Issued
NIAID E-242-2011-0-FR-08 Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Crystal Structures and Deep Sequencing FR EP 12782672.5 Issued
NIAID E-242-2011-0-DE-07 Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Crystal Structures and Deep Sequencing DE EP 12782672.5 Issued
NIAID E-242-2011-0-GB-09 Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Crystal Structures and Deep Sequencing GB EP 12782672.5 Issued
NIAID E-300-2009-5-US-07 NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE US National Stage 13/498,125 9175070 Issued PDF
NIAID E-300-2009-5-US-09 NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE US ORD 13/429,286 8637036 Issued PDF
NIAID E-242-2011-0-PCT-02 Isolation Of Novel Broadly Neutralizing Monoclonal Antibodies Against HIV-1 Using Epitope-specific Glycoprotein Probes To Identify HIV-1 Specific B-cells PCT PCT PCT/US2012/030436 Expired
NIAID E-300-2009-7-US-01 NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE US CIP 13/429,279 Abandoned
NIAID E-213-2011-1-PCT-01 NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE PCT PCT COMB PCT/US2012/030465 Expired
NCI E-078-2012-0-US-01 Anti-Mesothelin Chimeric Antigen Receptors US 61/614,612 Abandoned
NCATS E-188-2009-2-US-02 Aminothienopyridazine Inhibitors of TAU Assembly US National Stage 13/497,697 Abandoned
NCI E-148-2011-0-EP-06 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer EP National Stage 12710856.1 Issued
NCI E-148-2011-0-TR-36 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer TR EP 12710856.1 Issued
NCI E-148-2011-0-GB-25 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer GB EP 12710856.1 Issued
NCI E-148-2011-0-SE-33 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer SE EP 12710856.1 Issued
NCI E-148-2011-0-CH-20 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer CH EP 12710856.1 Issued
NCI E-148-2011-0-ES-23 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer ES EP 12710856.1 Issued